x

Search for a clinical trial

* (*) mandatory field

59 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

HAUTS-DE-FRANCE
LILLE

A multicenter phase II study of Imatinib in patients with metastatic ocular melanoma
CLCC Oscar Lambret
Département de cancérologie générale

FRANCE

ILE-DE-FRANCE
BOBIGNY

Glivec - Hydrea in recurrent glioblastoma (Phase II) - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

NOUVELLE AQUITAINE
POITIERS

GERMANY

Niedersachsen
HANNOVER

GERMANY

Sachsen
DRESDEN

GERMANY

Thüringen
JENA

ITALY

LOMBARDIA
MONZA

Ongoing trial
Long term side effects of imatinib on Chronic Myeloid Leukemia (CLM) patients.
Azienda Ospedaliera San Gerardo
Unità di Ricerca Clinica

ITALY

MARCHE
ANCONA

Ongoing trial
Low-dose oral Imatinib in the treatment of Scleroderma pulmonary involvement: a phase II pilot sutdy
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

NETHERLANDS

Gelderland
NIJMEGEN

NETHERLANDS

Zuid-Holland
ROTTERDAM

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
Erasmus MC - Erasmus Medisch Centrum
Kankercentrum Daniel den Hoed

SPAIN

Aragón
ZARAGOZA

UNITED KINGDOM

Merseyside
WIRRAL

Ongoing trial
ITEM: A phase II study of Imatinib in the treatment of patients with metastatic uveal melanoma
The Clatterbridge Cancer Centre NHS Foundation Trust
Clatterbridge Centre for Oncology

Multinational clinical trial(s)